The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.

Autor: Kotzin JJ; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Spencer SP; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., McCright SJ; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Kumar DBU; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, 06032, USA.; Department of Genetics and Genomic Sciences, University of Connecticut Health Center, Farmington, Connecticut, 06032, USA., Collet MA; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, 06032, USA., Mowel WK; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Elliott EN; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, 06032, USA., Uyar A; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, 06032, USA., Makiya MA; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892., Dunagin MC; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104., Harman CCD; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.; Howard Hughes Medical Institute, Yale University, New Haven, CT 06510, USA., Virtue AT; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Zhu S; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, 06032, USA., Bailis W; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA., Stein J; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.; Howard Hughes Medical Institute, Yale University, New Haven, CT 06510, USA., Hughes C; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.; Howard Hughes Medical Institute, Yale University, New Haven, CT 06510, USA., Raj A; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104., Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Goff LA; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA.; Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland 21205, USA., Klion AD; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892., Rinn JL; Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Williams A; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, 06032, USA.; Department of Genetics and Genomic Sciences, University of Connecticut Health Center, Farmington, Connecticut, 06032, USA., Flavell RA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.; Howard Hughes Medical Institute, Yale University, New Haven, CT 06510, USA., Henao-Mejia J; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Division of Transplant Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104.
Jazyk: angličtina
Zdroj: Nature [Nature] 2016 Sep 08; Vol. 537 (7619), pp. 239-243. Date of Electronic Publication: 2016 Aug 15.
DOI: 10.1038/nature19346
Abstrakt: Neutrophils, eosinophils and 'classical' monocytes collectively account for about 70% of human blood leukocytes and are among the shortest-lived cells in the body. Precise regulation of the lifespan of these myeloid cells is critical to maintain protective immune responses and minimize the deleterious consequences of prolonged inflammation. However, how the lifespan of these cells is strictly controlled remains largely unknown. Here we identify a long non-coding RNA that we termed Morrbid, which tightly controls the survival of neutrophils, eosinophils and classical monocytes in response to pro-survival cytokines in mice. To control the lifespan of these cells, Morrbid regulates the transcription of the neighbouring pro-apoptotic gene, Bcl2l11 (also known as Bim), by promoting the enrichment of the PRC2 complex at the Bcl2l11 promoter to maintain this gene in a poised state. Notably, Morrbid regulates this process in cis, enabling allele-specific control of Bcl2l11 transcription. Thus, in these highly inflammatory cells, changes in Morrbid levels provide a locus-specific regulatory mechanism that allows rapid control of apoptosis in response to extracellular pro-survival signals. As MORRBID is present in humans and dysregulated in individuals with hypereosinophilic syndrome, this long non-coding RNA may represent a potential therapeutic target for inflammatory disorders characterized by aberrant short-lived myeloid cell lifespan.
Databáze: MEDLINE
Externí odkaz: